(Q34528465)

2 August 2017

0 references

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (English)

1 reference

2 August 2017

A. C. Parrott

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

published in

Human Psychopharmacology

1 reference

2 August 2017

volume

16

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

557-577

1 reference

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

2 August 2017

cites work

1 reference

Ibiza uncovered: changes in substance use and sexual behaviour amongst young people visiting an international night-life resort.

21 January 2018

1 reference

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

21 January 2018

1 reference

Memory impairment in abstinent MDMA ("Ecstasy") users

21 January 2018

1 reference

MDMA and human sexual function

21 January 2018

1 reference

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

‘Ecstasy’ Psychosis and Flashbacks

21 January 2018

1 reference

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence

21 January 2018

1 reference

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

21 January 2018

1 reference

Auditory verbal learning in drug-free Ecstasy polydrug users.

21 January 2018

1 reference

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

21 January 2018

1 reference

The serotonin syndrome and its treatment

21 January 2018

1 reference

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

A method of conducting therapeutic sessions with MDMA.

21 January 2018

1 reference

Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

21 January 2018

1 reference

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

21 January 2018

1 reference

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

21 January 2018

1 reference

Ecstasy (MDMA) dependence.

21 January 2018

1 reference

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

21 January 2018

1 reference

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

21 January 2018

1 reference

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

Caveat emptor: editors beware

21 January 2018

1 reference

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

21 January 2018

1 reference

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

Congenital anomalies after prenatal ecstasy exposure.

21 January 2018

1 reference

Long term psychiatric and cognitive effects of MDMA use.

21 January 2018

1 reference

Drug use among college undergraduates: current use and 10-year trends

21 January 2018

1 reference

Ecstasy and neurodegeneration. Advice is that "less is more".

21 January 2018

1 reference

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

A review of the role of serotonin receptors in psychiatric disorders

21 January 2018

1 reference

Does cigarette smoking cause stress?

21 January 2018

1 reference

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

21 January 2018

1 reference

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

21 January 2018

1 reference

Ecstasy and new patterns of drug use: a normal population study.

21 January 2018

1 reference

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

21 January 2018

1 reference

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

21 January 2018

1 reference

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

21 January 2018

1 reference

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

21 January 2018

1 reference

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

21 January 2018

1 reference

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

21 January 2018

1 reference

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series

21 January 2018

1 reference

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

21 January 2018

1 reference

Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers.

21 January 2018

1 reference

Is the use of ecstasy and hallucinogens increasing? Results from a community study.

21 January 2018

1 reference

The background and chemistry of MDMA.

21 January 2018

1 reference

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

21 January 2018

1 reference

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

A pure amnestic syndrome after MDMA ("ecstasy") ingestion

21 January 2018

1 reference

Monitoring synthetic drug markets, trends, and public health

21 January 2018

1 reference

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

Caveat emptor: editors beware

21 January 2018

1 reference

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

Alcohol and drug use in UK university students.

21 January 2018

1 reference

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

21 January 2018

1 reference

Deconstructing Ecstasy: The Politics Of Mdma Research

21 January 2018

1 reference

Chemical analysis of ecstasy pills

21 January 2018

1 reference

7 January 2021

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

1 reference

7 January 2021

3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development.

1 reference

7 January 2021

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

7 January 2021

1 reference

7 January 2021

Serotonin syndrome: history and risk

1 reference

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

7 January 2021

Caveat emptor: researcher beware

1 reference

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

7 January 2021

Cigarette smoking does cause stress.

1 reference

7 January 2021

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

7 January 2021

Chronic atypical psychosis associated with MDMA ("ecstasy") abuse

1 reference

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

7 January 2021

Emergency medical assistance during a mass gathering

1 reference

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

7 January 2021

Is a single dose of MDMA harmless?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.351

1 reference

2 August 2017

1 reference